FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based spheroids to be utilized in clinical trials.
To help advance FibroBiologics' fibroblast-based therapies into the clinic, Charles River will conduct feasibility studies on FibroBiologics' cell manufacturing processes within its facility. Additionally, contingent upon entering into a master services agreement, Charles River would serve as the contract development and manufacturing organization (CDMO) responsible for producing drug products for certain FibroBiologics' clinical trials.
This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based spheroids to be utilized in clinical trials.
該協議是在達成預期的主服務協議之前達成的，該協議旨在開發和製造Fibrobiologics的主細胞庫、工作細胞庫和基於成纖維細胞的球體，用於臨床試驗。
To help advance FibroBiologics' fibroblast-based therapies into the clinic, Charles River will conduct feasibility studies on FibroBiologics' cell manufacturing processes within its facility. Additionally, contingent upon entering into a master services agreement, Charles River would serve as the contract development and manufacturing organization (CDMO) responsible for producing drug products for certain FibroBiologics' clinical trials.
爲了幫助Fibrobiologics的基於成纖維細胞的療法進入臨床，查爾斯·裏弗將在其設施內對Fibrobiologics的細胞製造過程進行可行性研究。此外，視簽訂主服務協議而定，查爾斯·裏弗將擔任合同開發和製造組織（CDMO），負責爲某些Fibrobiologics的臨床試驗生產藥品。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧